Background

Most anti-diarrhoeal preparations, stimulant laxatives and bulking agents for constipation do not contain significant amounts of sodium. However, osmotic laxatives do contain significant amounts of sodium and this should be considered if people take these preparations regularly. As for all laxatives, prolonged use is not usually recommended.

The attached list provides details of sodium content at individual dose and maximum dose level, along with associated limitations. The list can be used to help find similar formulations with lower sodium content.

Attachments

High sodium content can make some medicines unsuitable for patients on a salt-restricted diet. Alternative products exist for a range of conditions.
List of effervescent, soluble, dispersible and other preparations for treating pain, cold and flu that could contain high levels of sodium.
List of effervescent, soluble, dispersible and other preparations for treating indigestion and gastric disorders that could contain high levels of sodium.
List of miscellaneous effervescent, soluble, dispersible and other preparation that could contain high levels of sodium.
Doxazosin XL tablets should not routinely be prescribed. Guidance is provided on switching doxazosin XL tablets to standard release tablets.
A knowledge of the different types of enteral feeding tube is important when recommending options for medicines administration
An explanation as to why the source of vitamin D, or inactive ingredients (excipients) in products, may make preparations unsuitable for vegetarians or vegans.
Local decision makers should choose between the options for giving fidaxomicin orally. Licensing status and other factors affect decision making.
An overview of differences between mesalazine tablet preparations and clinical considerations when switching between preparations.